Metabolite-targeted LC-HRMS quantification of emerging indazole-based synthetic cannabinoids in urine samples from an addiction treatment cohort.
The continuous emergence of structurally diverse indazole-based synthetic cannabinoids (SCs) challenges routine analytical detection because parent compounds are rapidly metabolized and often absent in urine. Therefore, sensitive metabolite-targeted analytical methods are required for reliable exposure assessment. In t...